Quarterly report pursuant to Section 13 or 15(d)

Investment in account receivable (Details Narrative)

v3.22.1
Investment in account receivable (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Feb. 16, 2022
Apr. 10, 2015
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Warrants price per share     $ 2.11   $ 2.11
Warrants redemption price     $ 0.10    
Impairment of investments         $ 116,430
Amortization of debt discount     $ 13,470 $ 15,228  
Exchange Agreement [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Proceeds from investments   $ 117,000      
Annual installment receivable, term   11 years      
Shares issued, value   $ 1,287,000      
Shares issued, shares   757,059      
Investment in account receivable discount percent         17.87%
Annual payments $ 100,000        
Annual payment term 4 years        
Debt instrument, periodic payment $ 100        
Loss on investment     $ 41,930    
Exchange Agreement [Member] | Series D Warrants [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Warrants issued   757,059      
Warrants price per share   $ 1.60      
Warrants redemption price   $ 0.10